277 related articles for article (PubMed ID: 35444961)
1. Advancing a Human Onchocerciasis Vaccine From Antigen Discovery to Efficacy Studies Against Natural Infection of Cattle With
Zhan B; Bottazzi ME; Hotez PJ; Lustigman S
Front Cell Infect Microbiol; 2022; 12():869039. PubMed ID: 35444961
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of an Onchocerca ochengi microfilarial hamster model for onchocerciasis drug screens.
Mbah GE; Ayiseh RB; Cho-Ngwa F
BMC Infect Dis; 2016 Aug; 16(1):404. PubMed ID: 27515037
[TBL] [Abstract][Full Text] [Related]
3. Chemoprophylaxis of Onchocerca infections: in a controlled, prospective study ivermectin prevents calves becoming infected with O. ochengi.
Tchakouté VL; Bronsvoort M; Tanya V; Renz A; Trees AJ
Parasitology; 1999 Feb; 118 ( Pt 2)():195-9. PubMed ID: 10028534
[TBL] [Abstract][Full Text] [Related]
4. Onchocerca ochengi infections in cattle as a model for human onchocerciasis: recent developments.
Trees AJ; Graham SP; Renz A; Bianco AE; Tanya V
Parasitology; 2000; 120 Suppl():S133-42. PubMed ID: 10874716
[TBL] [Abstract][Full Text] [Related]
5. Onchocerca volvulus-specific antibody and cellular responses in onchocerciasis patients treated annually with ivermectin for 30 years and exposed to parasite transmission in central Togo.
Johanns SI; Gantin RG; Wangala B; Komlan K; Halatoko WA; Banla M; Karabou P; Luty AJ; Schulz-Key H; Köhler C; Soboslay PT
PLoS Negl Trop Dis; 2022 May; 16(5):e0010340. PubMed ID: 35503786
[TBL] [Abstract][Full Text] [Related]
6. Geospatial modeling of pre-intervention nodule prevalence of Onchocerca volvulus in Ethiopia as an aid to onchocerciasis elimination.
Shrestha H; McCulloch K; Hedtke SM; Grant WN
PLoS Negl Trop Dis; 2022 Jul; 16(7):e0010620. PubMed ID: 35849615
[TBL] [Abstract][Full Text] [Related]
7. Onchocerca ochengi: epidemiological evidence of cross-protection against Onchocerca volvulus in man.
Wahl G; Enyong P; Ngosso A; Schibel JM; Moyou R; Tubbesing H; Ekale D; Renz A
Parasitology; 1998 Apr; 116 ( Pt 4)():349-62. PubMed ID: 9585937
[TBL] [Abstract][Full Text] [Related]
8. Development of a recombinant vaccine against human onchocerciasis.
Abraham D; Graham-Brown J; Carter D; Gray SA; Hess JA; Makepeace BL; Lustigman S
Expert Rev Vaccines; 2021 Nov; 20(11):1459-1470. PubMed ID: 34488533
[TBL] [Abstract][Full Text] [Related]
9. Repurposing auranofin as a lead candidate for treatment of lymphatic filariasis and onchocerciasis.
Bulman CA; Bidlow CM; Lustigman S; Cho-Ngwa F; Williams D; Rascón AA; Tricoche N; Samje M; Bell A; Suzuki B; Lim KC; Supakorndej N; Supakorndej P; Wolfe AR; Knudsen GM; Chen S; Wilson C; Ang KH; Arkin M; Gut J; Franklin C; Marcellino C; McKerrow JH; Debnath A; Sakanari JA
PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003534. PubMed ID: 25700363
[TBL] [Abstract][Full Text] [Related]
10. Co-Administration of Adjuvanted Recombinant
Luu L; Bah GS; Okah-Nnane NH; Hartley CS; Glover AF; Walsh TR; Lian LY; Zhan B; Bottazzi ME; Abraham D; Petrovsky N; Bayang N; Tangwa B; Ayiseh RB; Mbah GE; Ekale DD; Tanya VN; Lustigman S; Makepeace BL; Graham-Brown J
Vaccines (Basel); 2022 May; 10(6):. PubMed ID: 35746469
[TBL] [Abstract][Full Text] [Related]
11. Human Onchocerciasis: Modelling the Potential Long-term Consequences of a Vaccination Programme.
Turner HC; Walker M; Lustigman S; Taylor DW; Basáñez MG
PLoS Negl Trop Dis; 2015; 9(7):e0003938. PubMed ID: 26186715
[TBL] [Abstract][Full Text] [Related]
12. Macrofilaricidal activity after doxycycline only treatment of Onchocerca volvulus in an area of Loa loa co-endemicity: a randomized controlled trial.
Turner JD; Tendongfor N; Esum M; Johnston KL; Langley RS; Ford L; Faragher B; Specht S; Mand S; Hoerauf A; Enyong P; Wanji S; Taylor MJ
PLoS Negl Trop Dis; 2010 Apr; 4(4):e660. PubMed ID: 20405054
[TBL] [Abstract][Full Text] [Related]
13. Doxycycline plus ivermectin versus ivermectin alone for treatment of patients with onchocerciasis.
Abegunde AT; Ahuja RM; Okafor NJ
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011146. PubMed ID: 26771164
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of small animal models for onchocerciasis and loiasis microfilaricide discovery.
Ayiseh RB; Mbah GE; Monya E; Ndi EM; Sakanari J; Lustigman S; Cho-Ngwa F
PLoS Negl Trop Dis; 2023 Feb; 17(2):e0011135. PubMed ID: 36827447
[TBL] [Abstract][Full Text] [Related]
15. Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.
Cano J; Basáñez MG; O'Hanlon SJ; Tekle AH; Wanji S; Zouré HG; Rebollo MP; Pullan RL
Parasit Vectors; 2018 Jan; 11(1):70. PubMed ID: 29382363
[TBL] [Abstract][Full Text] [Related]
16. Immunisation with a multivalent, subunit vaccine reduces patent infection in a natural bovine model of onchocerciasis during intense field exposure.
Makepeace BL; Jensen SA; Laney SJ; Nfon CK; Njongmeta LM; Tanya VN; Williams SA; Bianco AE; Trees AJ
PLoS Negl Trop Dis; 2009 Nov; 3(11):e544. PubMed ID: 19901988
[TBL] [Abstract][Full Text] [Related]
17. Optimized strategy for real-time qPCR detection of Onchocerca volvulus DNA in pooled Simulium sp. blackfly vectors.
Doherty M; Grant JR; Pilotte N; Bennuru S; Fischer K; Fischer PU; Lustigman S; Nutman TB; Pfarr K; Hoerauf A; Unnasch TR; Hassan HK; Wanji S; Lammie PJ; Ottesen E; Mackenzie C; Williams SA
PLoS Negl Trop Dis; 2023 Dec; 17(12):e0011815. PubMed ID: 38096317
[TBL] [Abstract][Full Text] [Related]
18. In a bovine model of onchocerciasis, protective immunity exists naturally, is absent in drug-cured hosts, and is induced by vaccination.
Tchakouté VL; Graham SP; Jensen SA; Makepeace BL; Nfon CK; Njongmeta LM; Lustigman S; Enyong PA; Tanya VN; Bianco AE; Trees AJ
Proc Natl Acad Sci U S A; 2006 Apr; 103(15):5971-6. PubMed ID: 16585501
[TBL] [Abstract][Full Text] [Related]
19. Combined benefits of annual mass treatment with ivermectin and cattle zooprophylaxis on the severity of human onchocerciasis in northern Cameroon.
Seidenfaden R; Fischer A; Bonow I; Ekale D; Tanya V; Renz A
Trop Med Int Health; 2001 Sep; 6(9):715-25. PubMed ID: 11555439
[TBL] [Abstract][Full Text] [Related]
20. Phytochemical analysis and in vitro anthelmintic activity of Lophira lanceolata (Ochnaceae) on the bovine parasite Onchocerca ochengi and on drug resistant strains of the free-living nematode Caenorhabditis elegans.
Kalmobé J; Ndjonka D; Boursou D; Vildina JD; Liebau E
BMC Complement Altern Med; 2017 Aug; 17(1):404. PubMed ID: 28806951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
